A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
收藏DataCite Commons2025-10-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011868/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).
提供机构：
Vivli
创建时间：
2025-10-17
